Followers | 199 |
Posts | 21795 |
Boards Moderated | 2 |
Alias Born | 11/07/2005 |
Thursday, July 21, 2016 12:12:29 PM
Moving those notes out of few hands and into one friendly hand is big. This takes away risk of uncontrolled conversions into market, and thus risk of sharp downside drop in price.
In addition, with all the gun violence in the news Im sure DTII has a number of funds knocking on door hoping to get in, and this reduces DTII need to have to turn to desperate toxic funders...HUGE!!!
8K says in talks with government groups, not sure if that is federal like TSA, or just school districts...but either way super bullish.
If anything with toxic notes now moved into friendly hands this could easily pop back to .40 range...now lets get production going!
DTII
Have a great low float, or killer chart to share with our group of traders?
Post it up on my new board!
Sweet Crude's - Low Float and Chart Plays (please join)
http://investorshub.advfn.com/boards/board.aspx?board_id=21852
Recent DTII News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 08:26:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/20/2023 10:23:35 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 12/15/2023 07:42:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/25/2023 08:12:07 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 09/15/2023 05:22:20 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 08/25/2023 09:10:05 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/15/2023 09:15:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 09:21:47 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 07/31/2023 06:45:49 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM